Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia. Here, IGF2BP1 is linked to B-cell acute lymphoblastic leukemia.